{
    "Trade/Device Name(s)": [
        "eQ-PCR LC Warfarin Genotyping Kit",
        "eQ-PCRTM LC Warfarin Genotyping kit"
    ],
    "Submitter Information": "TrimGen Corporation",
    "510(k) Number": "K073071",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070804"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "ODW",
        "NSU",
        "ODV"
    ],
    "Summary Letter Date": "January 20, 2009",
    "Summary Letter Received Date": "January 23, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3360"
    ],
    "Regulation Name(s)": [
        "Drug metabolizing enzyme genotyping system"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "chemistry"
    ],
    "Analyte(s)": [
        "CYP2C9*2 (C430T)",
        "CYP2C9*3 (A1075C)",
        "VKORC1 (-1639G>A)"
    ],
    "Specimen Type(s)": [
        "Peripheral blood",
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Roche Diagnostics LightCycler Real-Time PCR System model 1.2"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Melting curve analysis"
    ],
    "Methodologies": [
        "Genotyping",
        "Molecular SNP detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for eQ-PCR LC Warfarin Genotyping Kit using real-time PCR and melting curve analysis for SNP detection in CYP2C9 and VKORC1 genes from peripheral blood.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic assay to aid in identification of patients at risk for increased warfarin sensitivity by detecting specified SNPs in CYP2C9 and VKORC1 from EDTA-anticoagulated whole blood samples.",
    "fda_folder": "Toxicology"
}